These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 870000)

  • 1. Acquired dysfibrinogenaemia in acute and chronic liver disease.
    Lane DA; Scully MF; Thomas DP; Kakkar VV; Woolf IL; Williams R
    Br J Haematol; 1977 Feb; 35(2):301-8. PubMed ID: 870000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysfibrinogenaemia characterized by abnormal fibrin monomer polymerization and normal fibrinopeptide A release.
    Lane DA; Cuddigan B; VanRoss M; Kakkar VV
    Br J Haematol; 1980 Mar; 44(3):483-94. PubMed ID: 6769460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysfibrinogenemia associated with liver disease.
    Palascak JE; Martinez J
    J Clin Invest; 1977 Jul; 60(1):89-95. PubMed ID: 874092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of fibrinopeptide B release: comparison of fibrins produced by thrombin and Ancrod.
    Shen LL; Hermans J; McDonagh J; McDonagh RP
    Am J Physiol; 1977 Jun; 232(6):H629-33. PubMed ID: 879301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysfibrinogenaemia and liver cell growth.
    Barr RD; Allardyce M; Brunt PW; McPhie JL
    J Clin Pathol; 1978 Jan; 31(1):89-92. PubMed ID: 627621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal fibrin polymerization in liver disease.
    Green G; Thomson JM; Dymock IW; Poller L
    Br J Haematol; 1976 Nov; 34(3):427-39. PubMed ID: 186092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysfibrinogenaemia associated with a defect in the aggregation of the fibrin monomers (Almeria I fibrinogen). A preliminary study.
    Vila V; Regañon E; Fernandez-Pavon A; Aznar J
    Scand J Haematol; 1984 Nov; 33(5):460-5. PubMed ID: 6515329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An abnormal inherited fibrinogen (fibrinogen Genova) with delayed fibrin aggregation.
    Hassan HJ; Orlando M; Tonini GP; Casalbore P; Sarti A; Boeri E; Giacchino R; Tentori L; Mori PG
    Scand J Haematol; 1982 Oct; 29(4):287-94. PubMed ID: 7178834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital dysfibrinogenemia: fibrinogen Lille.
    Denninger MH; Finlayson JS; Reamer LA; Parquet-Gernez A; Goudemand M; Menache D
    Thromb Res; 1978 Sep; 13(3):453-66. PubMed ID: 741439
    [No Abstract]   [Full Text] [Related]  

  • 10. Acquired dysfibrinogenaemia in liver disease.
    Francis JL; Armstrong DJ
    J Clin Pathol; 1982 Jun; 35(6):667-72. PubMed ID: 7085917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of acquired dysfibrinogenaemia in liver disease.
    Soria J; Soria C; Ryckewaert JJ; Samama M; Thomson JM; Poller L
    Thromb Res; 1980 Jul 1-15; 19(1-2):29-41. PubMed ID: 7444857
    [No Abstract]   [Full Text] [Related]  

  • 12. Analysis of reptilase and thrombin-induced changes in fibrinogen subunits by isoelectric focussing.
    Exner T; Rickard KA; Kronenberg H
    Thromb Res; 1983 Aug; 31(3):489-97. PubMed ID: 20218004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of ancrod anticoagulation. A direct proteolytic effect on fibrin.
    Pizzo SV; Schwartz ML; Hill RL; McKee PA
    J Clin Invest; 1972 Nov; 51(11):2841-50. PubMed ID: 4263497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human fibrinogen heterogeneities: determination of the major Aalpha chain derivatives in blood.
    Galanakis DK; Mosesson MW
    Thromb Res; 1983 Aug; 31(3):403-13. PubMed ID: 20217997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired dysfibrinogenaemia masquerading as disseminated intravascular coagulation in acute pancreatitis.
    Wilde JT; Thomas WE; Lane DA; Greaves M; Preston FE
    J Clin Pathol; 1988 Jun; 41(6):615-8. PubMed ID: 3384995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An abnormal fibrinogen with delayed fibrinopeptide A release.
    Lane DA; VanRoss M; Kakkar VV; Bottomley KJ; Dhir K; Holt LP; MacIver JE
    Br J Haematol; 1980 Sep; 46(1):89-98. PubMed ID: 7426452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acquired dysfibrinogenemia in a child in the course of a liver disease].
    Maak B; Meyer M; Dietze H
    Monatsschr Kinderheilkd; 1990 Aug; 138(8):446-50. PubMed ID: 2215508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired dysfibrinogenaemia.
    Francis JL; Armstrong DJ
    Med Lab Sci; 1983 Apr; 40(2):165-75. PubMed ID: 6350786
    [No Abstract]   [Full Text] [Related]  

  • 19. Fibrinogen Matsumoto V: a variant with Aalpha19 Arg-->Gly (AGG-->GGG). Comparison between fibrin polymerization stimulated by thrombin or reptilase and fibrin monomer polymerization.
    Tanaka H; Terasawa F; Ito T; Tokunaga S; Ishida F; Kitano K; Kiyosawa K; Okumura N
    Thromb Haemost; 2001 Jan; 85(1):108-13. PubMed ID: 11204560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrin assembly after fibrinopeptide A release in model systems and human plasma studied with magnetic birefringence.
    Torbet J
    Biochem J; 1987 Jun; 244(3):633-7. PubMed ID: 3446182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.